Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives
ACS Omega · 10.11.2026 · 11 (44) · 68102-68126
DOI: 10.1021/acsomega.6c10567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 27.10.2026. Verfasst von Pan Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China. Die Arbeit nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Southwest Medical University, Luzhou Science and Technology Bureau, National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Myocardial infarction (MI) remains a leading cause of death worldwide, yet current therapeutic interventions offer limited capacity for functional cardiac regeneration. In recent years, hydrogels derived from natural products have emerged as compelling therapeutic platforms, attributed to their favorable biocompatibility, tunable biodegradability, and intrinsic biological activities. This review systematically summarizes natural product-derived hydrogels for MI repair, with particular emphasis on representative polysaccharide-based systems, including chitosan, alginate, and hyaluronic acid. It also discusses small-molecule self-assembled hydrogels, such as glycyrrhizic acid, puerarin, and rhein, as well as hydrogel-based extracellular vesicle delivery systems, as complementary therapeutic strategies. We further highlight the multifaceted mechanisms through which these materials ameliorate the pathological cardiac microenvironment, including structural reinforcement, restoration of electrical conduction, modulation of the immune response, promotion of neovascularization, and scavenging of reactive oxygen species. Critical challenges impeding clinical translation, such as long-term biocompatibility, targeted delivery efficiency, and scalable manufacturing, are thoroughly examined, alongside emerging directions including stimuli-responsive systems and three-dimensional bioprinting technologies. Although natural product-derived hydrogels hold considerable promise for cardiac repair, overcoming existing technical hurdles through continued interdisciplinary research remains imperative for their successful transition from bench to bedside.
Autor:innen und Institutionen
- Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
- Department of Gynecology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
ORCID-Profile: Pan Liang, Mijia Zhang
Förderung
- Southwest Medical University
- Luzhou Science and Technology Bureau
- National Administration of Traditional Chinese Medicine
Zitieren
APA
Liang, P., Zhang, Y., Ye, T., Li, J., Xiong, A., Zhang, S., Wang, Y., Xu, R., & Zhang, M. (2026). Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives. ACS Omega, 11(44), 68102-68126. https://doi.org/10.1021/acsomega.6c10567
Vancouver
Liang P, Zhang Y, Ye T, Li J, Xiong A, Zhang S, et al. Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives. ACS Omega. 2026;11(44):68102-68126. doi:10.1021/acsomega.6c10567
BibTeX
@article{Liang2026,
author = {Liang, Pan and Zhang, Yujie and Ye, Tao and Li, Jiangxue and Xiong, Anrui and Zhang, Shuhan and Wang, Yongzhou and Xu, Ruxiang and Zhang, Mijia},
title = {Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {44},
pages = {68102--68126},
doi = {10.1021/acsomega.6c10567}
}
EUVIMED